A key driver for the market is the continuous advancement in stent technology. Drug-eluting stents (DES) have become the gold standard, as they are coated with medication that helps prevent the artery from re-narrowing after the procedure. Bioresorbable vascular scaffolds (BVS), which dissolve over time, are also gaining traction, offering a permanent solution without leaving a permanent implant behind. These innovations are improving patient outcomes and expanding the use of stents in more complex cases. https://www.marketresearchfutu....re.com/reports/coron